CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-01 | Baumann Werner Director | Grant or award | +107 | $234.27 | $25K | 1,883 |
| 2024-11-01 | Tyler Lauren M Director | Grant or award | +107 | $234.27 | $25K | 1,883 |
| 2024-11-01 | Clyburn Frank Director | Grant or award | +368 | $234.27 | $86K | 368 |
| 2024-10-22 | COLLIS STEVEN H Executive Chairman | Option exercise | +21,509 | $89.58 | $1.9M | 306,597 |
| 2024-10-22 | COLLIS STEVEN H Executive Chairman | Sale | −21,509 | $235.80 | $5.1M | 285,088 |
| 2024-10-22 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) | −21,509 | 21,509 | ||
| 2024-09-17 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +21,509 | $89.58 | $1.9M | 306,597 |
| 2024-09-17 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −21,509 | $241.01 | $5.2M | 285,088 |
| 2024-09-17 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −21,509 | 43,018 | ||
| 2024-08-20 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,754 | $89.58 | $963K | 295,842 |
| 2024-08-20 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,754 | $239.13 | $2.6M | 285,088 |
| 2024-08-20 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,754 | 64,527 | ||
| 2024-08-06 | Battaglia Silvana Executive Vice President | Sale | −1,473 | $242.69 | $357K | 10,948.08 |
| 2024-08-05 | GREENBERG LON R Director | Gift | −5,000 | 20,062 | ||
| 2024-08-01 | NALLY DENNIS M Director | Grant or award | +128 | $244.46 | $31K | 12,084 |
| 2024-08-01 | Baumann Werner Director | Grant or award | +103 | $244.46 | $25K | 1,776 |
| 2024-08-01 | Tyler Lauren M Director | Grant or award | +103 | $244.46 | $25K | 1,776 |
| 2024-08-01 | Walgreens Boots Alliance, Inc. 10% owner | Sale | −4,438,171 | $240.56 | $1.1B | 19,980,000 |
| 2024-07-16 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,755 | $89.58 | $963K | 295,843 |
| 2024-07-16 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,755 | $222.12 | $2.4M | 285,088 |
Page 19 of 40 · 797 trades